These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17326063)
1. Transcoronary concentration gradient of sCD40L and hsCRP in patients with coronary heart disease. Wang Y; Li L; Tan HW; Yu GS; Ma ZY; Zhao YX; Zhang Y Clin Cardiol; 2007 Feb; 30(2):86-91. PubMed ID: 17326063 [TBL] [Abstract][Full Text] [Related]
2. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting. Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155 [TBL] [Abstract][Full Text] [Related]
3. Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein. Ong P; Carro A; Athanasiadis A; Borgulya G; Schäufele T; Ratge D; Gaze D; Sechtem U; Kaski JC Coron Artery Dis; 2015 Mar; 26(2):126-32. PubMed ID: 25405929 [TBL] [Abstract][Full Text] [Related]
4. Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction. Ohashi Y; Kawashima S; Mori T; Terashima M; Ichikawa S; Ejiri J; Awano K Int J Cardiol; 2006 Sep; 112(1):52-8. PubMed ID: 16376442 [TBL] [Abstract][Full Text] [Related]
5. Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand. Liang KW; Sheu WH; Lee WL; Liu TJ; Ting CT; Chen YT; Lee WJ Can J Cardiol; 2006 Jun; 22(8):691-6. PubMed ID: 16802000 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB; Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum sST2 and sCD40L values in patients with microvascular angina. Aslan G; Polat V; Bozcali E; Opan S; Çetin N; Ural D Microvasc Res; 2019 Mar; 122():85-93. PubMed ID: 30502363 [TBL] [Abstract][Full Text] [Related]
8. [Serum soluble CD40L level and its application in coronary heart disease]. Li J; Peng DQ; Zhao SP Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):611-4. PubMed ID: 15804073 [TBL] [Abstract][Full Text] [Related]
9. [Correlation between serum inflammatory cytokine levels and fibrous cap thickness of fibrofatty plaque in coronary culprit lesions]. Zhong Y; Ye F; You W; Wu ZM Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):566-571. PubMed ID: 28738484 [No Abstract] [Full Text] [Related]
10. [Relationship between serum vasoactive factors and plaque morphology in patients with acute coronary syndrome]. Kang WQ; Song DL; Guo XG Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1020-3. PubMed ID: 18269823 [TBL] [Abstract][Full Text] [Related]
11. [Urgent percutaneous coronary intervention leads to a decrease in serum concentrations of soluble CD40 ligand]. Ratković N; Romanović R; Jovelić A; Gligić B; Rafajlovski S; Vojvodić D; Obradović S Vojnosanit Pregl; 2010 Sep; 67(9):732-40. PubMed ID: 20954412 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease. Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363 [TBL] [Abstract][Full Text] [Related]
13. Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography. Rondina MT; Lappé JM; Carlquist JF; Muhlestein JB; Kolek MJ; Horne BD; Pearson RR; Anderson JL Cardiology; 2008; 109(3):196-201. PubMed ID: 17726321 [TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease. Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166 [TBL] [Abstract][Full Text] [Related]
15. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein. Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470 [TBL] [Abstract][Full Text] [Related]
16. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease. Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837 [TBL] [Abstract][Full Text] [Related]
17. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance]. Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128 [TBL] [Abstract][Full Text] [Related]
18. Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction. Lorgis L; Amoureux S; de Maistre E; Sicard P; Bejot Y; Zeller M; Vergely C; Sequeira-Le Grand A; Lagrost AC; Berchoud J; Cottin Y; Rochette L Fundam Clin Pharmacol; 2010 Aug; 24(4):525-30. PubMed ID: 19909348 [TBL] [Abstract][Full Text] [Related]
19. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome. Unek IT; Bayraktar F; Solmaz D; Ellidokuz H; Yuksel F; Sisman AR; Yesil S Metabolism; 2010 Mar; 59(3):305-13. PubMed ID: 20006362 [TBL] [Abstract][Full Text] [Related]
20. [The research of establishing discriminant function for patients with angina pectoris by stepwise analysis based on serum inflammatory factors]. Chen ZB; Liang YB; Tang H; Wang ZH; Zeng LJ; Wu JG; Li ZY; Ma ZF Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Dec; 24(12):713-6. PubMed ID: 23168197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]